Immutrix Overview
- Founded
-
2009
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$750K
- Investors
-
1
Immutrix General Information
Description
Developer of a medical device designed to remove inflammatory mediators and toxins from the blood. The company's device uses proprietary adsorbents and smart hollow-fiber membranes to efficiently and selectively remove a broad range of pro-inflammatory mediators from blood, enabling clinicians to offer rapid response treatments to remove toxins, poisons, and biological modifiers.
Contact Information
Website
www.immutrix.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
- 3620 Homestead Street
- Rapid City, SD 57703
- United States
+1 (605) 000-0000
Immutrix Timeline
Immutrix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 13-Jul-2020 | $750K | 0000 | Completed | Generating Revenue | |
| 4. Debt - PPP | 10-Apr-2020 | 00000 | 000.00 | Completed | Clinical Trials - General | |
| 3. Later Stage VC | 01-Oct-2018 | 00.000 | 000.00 | Completed | Clinical Trials - General | |
| 2. Later Stage VC | 19-Jul-2016 | $4.09M | $7.99M | Completed | Clinical Trials - General | |
| 1. Seed Round | 20-Oct-2015 | $3.9M | $3.9M | 000.00 | Completed | Startup |
Immutrix Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00 | 00.0 | 00.0 | 00 | 00.0 | 0.00 |
Immutrix Patents
Immutrix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3867638-A1 | Adsorption and binding of plasma molecules and particles to carbon | Pending | 17-Oct-2018 | 000000000 | |
| AU-2019362006-A1 | Adsorption and binding of plasma molecules and particles to carbon | Pending | 17-Oct-2018 | 000000000 | |
| CA-3116721-A1 | Adsorption and binding of plasma molecules and particles to carbon | Pending | 17-Oct-2018 | 000000000 | |
| EP-3867638-A4 | Adsorption and binding of plasma molecules and particles to carbon | Pending | 17-Oct-2018 | 000000000 | 0 |
| US-20220120648-A1 | Adsorption and binding of plasma molecules and particles to carbon | Pending | 17-Oct-2018 | B01J20/20 |
Immutrix Executive Team (6)
Immutrix Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Brent Phillips | Immutrix | Board Member | 000 0000 |
| Carol Rae | Immutrix | Co-Founder, Co-Chief Executive Officer, President & Chairwoman | 000 0000 |
| Craig Hansen | Self | Board Member | 000 0000 |
| Leroy Ketel | Immutrix | Chief Financial Officer & Board Member | 000 0000 |
| Stephanie Durso | Immutrix | Board Member | 000 0000 |
Immutrix Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Immutrix Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| SDR Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |